# BlueSync Field Evaluation

> **NCT03518658** · — · COMPLETED · sponsor: **Medtronic Cardiac Rhythm and Heart Failure** · enrollment: 257 (actual)

## Conditions studied

- Bradycardia

## Interventions

- **OTHER:** Evaluation Group
- **OTHER:** Control Group (Historical)

## Key facts

- **NCT ID:** NCT03518658
- **Lead sponsor:** Medtronic Cardiac Rhythm and Heart Failure
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-02
- **Primary completion:** 2019-12-29
- **Final completion:** 2019-12-29
- **Target enrollment:** 257 (ACTUAL)
- **Last updated:** 2021-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03518658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03518658, "BlueSync Field Evaluation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03518658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*